EDErnst R. Dow
Ernst R. Dow
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ernst R. Dow has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Bruce Konicek
Eli Lilly and Company, Indianapolis, Indiana, USA
2 shared publications - Venkatesh Krishnan
Eli Lilly and Company, Indianapolis, Indiana, USA
2 shared publications - Andrew Blauvelt
Oregon Medical Research Center, Portland, USA
1 shared publication - Brian J. Nickoloff
Net2Source, Somerset, Indiana, USA
1 shared publication - David C. Gemperline
Eli Lilly and Company, Indianapolis, Indiana, USA
1 shared publication - Gaia Gallo
Eli Lilly and Company, Indianapolis, IN, USA
1 shared publication
Latest Publications
- Open Access
- 15 August 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (3) , 669-677.e6
Comparative Molecular Analysis of IL-17A and IL-23 Pathway Inhibition in Moderate-to-Severe Psoriasis: 4-Week Results from IXORA-R
- 15 August 2025
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 146 (3) , 669-677.e6
Open AccessComparative Molecular Analysis of IL-17A and IL-23 Pathway Inhibition in Moderate-to-Severe Psoriasis: 4-Week Results from IXORA-R
- Open Access
- 24 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (9) , 1689-1699
IL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis
- 24 March 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 143 (9) , 1689-1699
Open AccessIL17A Blockade with Ixekizumab Suppresses MuvB Signaling in Clinical Psoriasis